Lyell Immunopharma, Inc.
400 E Jamie Ct #301
South San Francisco
2 articles with Lyell Immunopharma, Inc.
Orca Bio and Lyell Immunopharma today announced a research partnership to jointly identify next generation T cell therapies that will combine precision purification T cell technologies from Orca Bio with the scientific expertise in T cell biology from Lyell
Sarah Cannon and Lyell Immunopharma Announce Collaboration to Advance Development and Patient Access to T-Cell Therapies
Sarah Cannon, the Cancer Institute of HCA Healthcare, and Lyell Immunopharma announced a strategic collaboration for the advancement of oncology-focused immune-effector, or T-Cell, therapies.